LM

Laura M. Periman

Periman Eye Institute

Affiliated withPeriman Eye Institute

Research Area

Biography

Laura M. Periman has not added Biography.
If you are Laura M. Periman and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title	2025
Publication title	2025

Other Publications

Article	Year
Improving Tolerance and Compliance with Topical Immunomodulators Using Micro-Emulsion Lipid Layer Artificial Tears. Clinical ophthalmology (Auckland, N.Z.)\| PubMed ID: 32753836	2020
A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments. Clinical ophthalmology (Auckland, N.Z.)\| PubMed ID: 33299295	2020
The roles of sex and gender in women's eye health disparities in the United States. Biology of sex differences\| PubMed ID: 34670620	2021
Meibomian Gland Dysfunction: A Dermatological Perspective on Pathogenesis and Treatment Outlook. Clinical ophthalmology (Auckland, N.Z.)\| PubMed ID: 34785886	2021
Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists. Annals of medicine\| PubMed ID: 36576348	2023
Bilateral Effect of OC-01 (Varenicline Solution) Nasal Spray for Treatment of Signs and Symptoms in Individuals with Mild, Moderate, and Severe Dry Eye Disease. Clinical therapeutics\| PubMed ID: 36763994	2022
The impact of Demodex blepharitis on patient symptoms and daily life. Optometry and vision science : official publication of the American Academy of Optometry\| PubMed ID: 38546756	2024
Efficacy and safety of a lipid-containing artificial tear compared with a non-lipid containing tear: a randomized clinical trial. BMC ophthalmology\| PubMed ID: 39379885	2024
Differentiating Between Perfluorohexyloctane Ophthalmic Solution and Water-Free Cyclosporine Ophthalmic Solution 0.1% for Dry Eye Disease: A Review of Preclinical and Clinical Characteristic... Ophthalmology and therapy\| PubMed ID: 39775405	2025
Safety and Efficacy of Lotilaner Ophthalmic Solution (0.25%) in Treating Demodex Blepharitis: Pooled Analysis of Two Pivotal Trials. Ophthalmology and therapy\| PubMed ID: 39873946	2025
Recalcitrant Dry Eye Disease in a 31-Year-Old Female: Favorable Outcomes Following Complete Ocular Lavage Facilitated by an Irrigating Eyelid Retractor. Cureus\| PubMed ID: 40062090	2025
The patient journey and burden of disease in blepharitis in the United States. Journal of medical economics\| PubMed ID: 40314599	2025
The Expert Panel on Treatment and Eyelid Health (DEPTH) Consensus Regarding the Preferred Treatment for Blepharitis. Clinical ophthalmology (Auckland, N.Z.)\| PubMed ID: 40551956	2025
Topical pharmacologic treatments for dry eye disease: A systematic review. The ocular surface\| PubMed ID: 40749992	2025

Copyright © 2026 MyJoVE Corporation. All rights reserved.